Orient Pharma Co., Ltd. (TPEX:4166)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
24.70
+0.40 (1.65%)
At close: Dec 5, 2025

Orient Pharma Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Cash & Equivalents
535.3384.583.3276.43130.9249.58
Upgrade
Short-Term Investments
9.824.829.820.820.8140.8
Upgrade
Cash & Short-Term Investments
545.13109.3113.1297.23151.72190.38
Upgrade
Cash Growth
--3.38%16.34%-35.92%-20.30%227.64%
Upgrade
Accounts Receivable
240.8278.18179.3169.3963.0978.2
Upgrade
Other Receivables
10.0610.368.1612.9116.822.35
Upgrade
Receivables
250.86288.54187.4782.379.980.56
Upgrade
Inventory
352.22279.56233.97194.18156.88138.64
Upgrade
Prepaid Expenses
26.1344.125839.1830.9114.75
Upgrade
Other Current Assets
9.516.9129.710.2419.899.5
Upgrade
Total Current Assets
1,184728.43622.25423.12439.31433.83
Upgrade
Property, Plant & Equipment
850.08891.83944.96903.28769.71792.66
Upgrade
Long-Term Investments
14.6813.651.883.051.753.13
Upgrade
Other Intangible Assets
425.62471.83532.6611.913.7525.36
Upgrade
Long-Term Deferred Tax Assets
372.11397.98451.46452.04439.2428.01
Upgrade
Other Long-Term Assets
40.7716.879.4754.18100.160.82
Upgrade
Total Assets
2,8872,5212,5631,8481,7641,744
Upgrade
Accounts Payable
69.1536.1455.5761.9719.628.63
Upgrade
Accrued Expenses
65.269.8262.0453.559.07115.75
Upgrade
Short-Term Debt
-250314.568.5161.532
Upgrade
Current Portion of Long-Term Debt
-4060.7124.0823.8323.47
Upgrade
Current Portion of Leases
16.8818.4417.9514.928.223.35
Upgrade
Current Unearned Revenue
63.464.5122.0164.8778.0744.73
Upgrade
Other Current Liabilities
7.698.3530.5663.2269.172.33
Upgrade
Total Current Liabilities
222.31487.25563.35351.06419.46250.25
Upgrade
Long-Term Debt
-42.1112.06178.79111.8152.62
Upgrade
Long-Term Leases
183.7195.95211.67221.86109.67112.26
Upgrade
Pension & Post-Retirement Benefits
5.985.865.095.946.859.67
Upgrade
Long-Term Deferred Tax Liabilities
1.571.84--0.130.01
Upgrade
Other Long-Term Liabilities
-----1.6
Upgrade
Total Liabilities
413.56733892.18757.65647.9526.41
Upgrade
Common Stock
2,4302,2302,2301,8701,8701,870
Upgrade
Additional Paid-In Capital
369.051,1301,130932.15932.15932.23
Upgrade
Retained Earnings
-332.21-1,579-1,686-1,709-1,682-1,581
Upgrade
Comprehensive Income & Other
6.356.05-3.83-2.89-4.6-3.63
Upgrade
Shareholders' Equity
2,4741,7881,6701,0901,1161,217
Upgrade
Total Liabilities & Equity
2,8872,5212,5631,8481,7641,744
Upgrade
Total Debt
200.57546.49716.9508.15415.01323.7
Upgrade
Net Cash (Debt)
344.56-437.19-603.78-410.92-263.29-133.32
Upgrade
Net Cash Per Share
1.53-1.96-2.71-2.20-1.41-0.79
Upgrade
Filing Date Shares Outstanding
243.04223.04223.04187187187.01
Upgrade
Total Common Shares Outstanding
243.04223.04223.04187187187.01
Upgrade
Working Capital
961.53241.1858.972.0719.86183.58
Upgrade
Book Value Per Share
10.188.017.495.835.976.51
Upgrade
Tangible Book Value
2,0481,3161,1381,0781,1021,192
Upgrade
Tangible Book Value Per Share
8.435.905.105.765.896.37
Upgrade
Buildings
796.44794.16786.78744.9682.91682.83
Upgrade
Machinery
450.4439.37430.96367.95361.11340.78
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.